HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clearance of xenon-133 from bone marrow in patients with small-cell lung cancer.

Abstract
The aim of this study was to estimate bone-marrow blood flow (BMBF) in man and to correlate this with myelosuppression induced by cytostatic treatment dosed as a function of surface area. Twenty-four patients suffering from small-cell lung cancer participated in the study. Blood flow was measured with the xenon-133 washout technique. The 133Xe clearance measurement took place in conjunction with the pre-treatment bone-marrow staging procedure (ad modern Radner). Tissue samples were taken for microscopy and for the determination of the blood-to-tissue partition coefficient lambda. After the bone-marrow aspiration, 0.1-0.2 ml of 133Xe in saline was injected into the bone marrow and the cannula was removed. Following a hyperaemic phase of 12 min (7-16 min), monoexponential washouts were demonstrated. The median washout rate constant was 0.0063 min-1 (0.0038-0.0098 min-1). Lambda values of 0.3-3.5 ml g were found, but microscopy of the bone marrow showed a fairly large admixture of peripheral blood. Therefore, the lambda values should be taken with caution and absolute blood-flow values were not calculated. The results demonstrated no correlation between 133Xe clearance from crista iliaca and leucocyte or platelet suppression.
AuthorsL J Petersen, L Friberg, J Jensen, J Bülow, M Hansen, J Madsen
JournalScandinavian journal of clinical and laboratory investigation (Scand J Clin Lab Invest) Vol. 51 Issue 6 Pg. 559-63 (Oct 1991) ISSN: 0036-5513 [Print] England
PMID1662828 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Xenon Radioisotopes
Topics
  • Aged
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Bone Marrow (blood supply, metabolism)
  • Carcinoma, Small Cell (drug therapy, metabolism)
  • Female
  • Humans
  • Leukocyte Count (drug effects)
  • Lung Neoplasms (drug therapy, metabolism)
  • Male
  • Middle Aged
  • Platelet Count (drug effects)
  • Regional Blood Flow (physiology, radiation effects)
  • Regression Analysis
  • Xenon Radioisotopes (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: